MENU
+Compare
LPTX
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$2.55
Change
-$0.03 (-1.16%)
Capitalization
97.71M

LPTX Leap Therapeutics Forecast, Technical & Fundamental Analysis

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LPTX with price predictions
Jan 08, 2025

LPTX's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for LPTX moved out of overbought territory on January 08, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 instances where the indicator moved out of the overbought zone. In of the 33 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for LPTX crossed bearishly below the 50-day moving average on December 20, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LPTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LPTX broke above its upper Bollinger Band on January 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on LPTX as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LPTX just turned positive on January 02, 2025. Looking at past instances where LPTX's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

LPTX moved above its 50-day moving average on January 02, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LPTX advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.996) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). LPTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LPTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LPTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LPTX is expected to report earnings to fall 72.50% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports
Q2'23
Est.
$-0.09
Q1'23
Missed
by $0.23
Q4'22
Est.
$-0.11
Q3'22
Missed
by $0.01
Q2'22
Missed
by $0.05
The last earnings report on May 15 showed earnings per share of -31 cents, missing the estimate of -8 cents. With 678.22K shares outstanding, the current market capitalization sits at 97.71M.
A.I. Advisor
published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LBSR0.130.01
+11.70%
Liberty Star Uranium & Metals Corp.
SGBLY12.010.34
+2.91%
Standard Bank Group Ltd.
MQBKY144.160.37
+0.26%
Macquarie Group, Ltd.
SKLTY27.30-0.41
-1.46%
Seek Ltd
PTHRF0.45-0.01
-1.77%
Pantheon Resources Plc

LPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-1.16%
AXON - LPTX
40%
Loosely correlated
+1.37%
AMRN - LPTX
35%
Loosely correlated
+0.72%
NRIX - LPTX
33%
Poorly correlated
-1.80%
GLUE - LPTX
30%
Poorly correlated
-1.82%
KYMR - LPTX
30%
Poorly correlated
+0.79%
More